Literature DB >> 27126457

Intraoperative MRI for deep brain stimulation lead placement in Parkinson's disease: 1 year motor and neuropsychological outcomes.

Christos Sidiropoulos1, Richard Rammo2, Brad Merker3, Abhimanyu Mahajan4, Peter LeWitt5, Patricia Kaminski5, Melissa Womble3, Adrianna Zec3, Danette Taylor5,6, Julia Wall5,2, Jason M Schwalb2.   

Abstract

Traditional deep brain stimulation requires intraoperative neurophysiological confirmation of electrode placement. Recently, purely image guided methods are being evaluated as to their clinical efficacy in comparison to surgery using microelectrode recordings. We used the ClearPoint(®) system to place electrodes in both the subthalamic nucleus and globus pallidus internus in patients with advanced Parkinson's disease. Off medication UPDRS scores were assessed before and 1 year after surgery as well as pre- and 1 year post-operative neuropsychological outcomes. Targeting precision was also assessed. Patients implanted in the subthalamic nucleus improved by 46.2 % in their UPDRS scores post-operatively (p = 0.03) whereas the globus pallidus group improved by 41 % (p = 0.06). There were no significant adverse neuropsychological outcomes in either group of patients. Mean radial error for the STN group was 1.2 ± 0.7 mm and for the GPi group 0.8 mm ± 0.3 mm. Image guided DBS using the ClearPoint(®)system has high targeting precision with robust clinical outcomes. Our data are in accord with recent studies using the same or similar technologies and provide a rationale for a large comparative study of image-guided versus microelectrode guided DBS.

Entities:  

Keywords:  Deep brain stimulation; Globus pallidus; Intraoperative MRI; Parkinson’s disease; Subthalamic nucleus

Mesh:

Year:  2016        PMID: 27126457     DOI: 10.1007/s00415-016-8125-0

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  29 in total

1.  Neuropsychological outcome after deep brain stimulation for Parkinson disease.

Authors:  Vincent J J Odekerken; Judith A Boel; Gert J Geurtsen; Ben A Schmand; I P Dekker; Rob J de Haan; P Richard Schuurman; Rob M A de Bie
Journal:  Neurology       Date:  2015-02-27       Impact factor: 9.910

Review 2.  Test review: Delis-Kaplan executive function system.

Authors:  Susan Homack; Donghyung Lee; Cynthia A Riccio
Journal:  J Clin Exp Neuropsychol       Date:  2005-07       Impact factor: 2.475

3.  Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease.

Authors:  L V Laitinen; A T Bergenheim; M I Hariz
Journal:  J Neurosurg       Date:  1992-01       Impact factor: 5.115

4.  Quantification of true in vivo (application) accuracy in cranial image-guided surgery: influence of mode of patient registration.

Authors:  Christopher R Mascott; Jean-Christophe Sol; Philippe Bousquet; Jacques Lagarrigue; Yves Lazorthes; Valérie Lauwers-Cances
Journal:  Neurosurgery       Date:  2006-07       Impact factor: 4.654

5.  The core assessment program for intracerebral transplantation.

Authors:  A E Lang; A L Benabid; W C Koller; A M Lozano; J A Obeso; C W Olanow; P Pollak
Journal:  Mov Disord       Date:  1995-07       Impact factor: 10.338

6.  Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease.

Authors:  Valerie C Anderson; Kim J Burchiel; Penelope Hogarth; Jacques Favre; John P Hammerstad
Journal:  Arch Neurol       Date:  2005-04

7.  Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease.

Authors:  Kenneth A Follett; Frances M Weaver; Matthew Stern; Kwan Hur; Crystal L Harris; Ping Luo; William J Marks; Johannes Rothlind; Oren Sagher; Claudia Moy; Rajesh Pahwa; Kim Burchiel; Penelope Hogarth; Eugene C Lai; John E Duda; Kathryn Holloway; Ali Samii; Stacy Horn; Jeff M Bronstein; Gatana Stoner; Philip A Starr; Richard Simpson; Gordon Baltuch; Antonio De Salles; Grant D Huang; Domenic J Reda
Journal:  N Engl J Med       Date:  2010-06-03       Impact factor: 91.245

8.  The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity.

Authors:  C Randolph; M C Tierney; E Mohr; T N Chase
Journal:  J Clin Exp Neuropsychol       Date:  1998-06       Impact factor: 2.475

9.  Clinical outcomes of PD patients having bilateral STN DBS using high-field interventional MR-imaging for lead placement.

Authors:  Jill L Ostrem; Nicholas B Galifianakis; Leslie C Markun; Jamie K Grace; Alastair J Martin; Philip A Starr; Paul S Larson
Journal:  Clin Neurol Neurosurg       Date:  2012-09-01       Impact factor: 1.876

10.  Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson's disease.

Authors:  Jill L Ostrem; Nathan Ziman; Nicholas B Galifianakis; Philip A Starr; Marta San Luciano; Maya Katz; Caroline A Racine; Alastair J Martin; Leslie C Markun; Paul S Larson
Journal:  J Neurosurg       Date:  2015-10-23       Impact factor: 5.115

View more
  6 in total

Review 1.  Gene Therapy for Neurodegenerative Diseases.

Authors:  Vivek Sudhakar; R Mark Richardson
Journal:  Neurotherapeutics       Date:  2019-01       Impact factor: 7.620

2.  Asleep Deep Brain Stimulation of the Nucleus Ventralis Intermedius for Essential Tremor Using Indirect Targeting and Interventional Magnetic Resonance Imaging: Single-Institution Case Series.

Authors:  Nicholas Gravbrot; Aaron Burket; Manojkumar Saranathan; Willard S Kasoff
Journal:  Mov Disord Clin Pract       Date:  2020-04-27

Review 3.  Awake versus Asleep Deep Brain Stimulation Surgery: Technical Considerations and Critical Review of the Literature.

Authors:  Ryan B Kochanski; Sepehr Sani
Journal:  Brain Sci       Date:  2018-01-19

Review 4.  Some Clinically Useful Information that Neuropsychology Provides Patients, Carepartners, Neurologists, and Neurosurgeons About Deep Brain Stimulation for Parkinson's Disease.

Authors:  Alexander I Tröster
Journal:  Arch Clin Neuropsychol       Date:  2017-11-01       Impact factor: 2.813

5.  The Role of Intraoperative MRI in Awake Neurosurgical Procedures: A Systematic Review.

Authors:  Tumul Chowdhury; Frederick A Zeiler; Gyaninder P Singh; Abseret Hailu; Hal Loewen; Bernhard Schaller; Ronald B Cappellani; Michael West
Journal:  Front Oncol       Date:  2018-10-10       Impact factor: 6.244

Review 6.  Data-driven evolution of neurosurgical gene therapy delivery in Parkinson's disease.

Authors:  R Mark Richardson; Krystof S Bankiewicz; Chadwick W Christine; Amber D Van Laar; Robert E Gross; Russell Lonser; Stewart A Factor; Sandra K Kostyk; Adrian P Kells; Bernard Ravina; Paul S Larson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2020-07-30       Impact factor: 10.154

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.